Youwei Zhang

发表

Gut microbiome for predicting immune checkpoint blockade-associated adverse events

Jie Hong, Xiao-Zhu Lin, T. Tong, 2024, Genome medicine.

Multi-kingdom gut microbiota analyses define bacterial-fungal interplay and microbial markers of pan-cancer immunotherapy across cohorts.

Jie Hong, Lijun Ning, Baoqin Xuan, 2023, Cell host & microbe.

Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts

Jie Hong, Lijun Ning, Baoqin Xuan, 2023, Nature communications.

A specific enterotype derived from gut microbiome of older individuals enables favorable responses to immune checkpoint blockade therapy.

Jie Hong, Lijun Ning, Baoqin Xuan, 2024, Cell host & microbe.